Phase 3 Readout~month

Phase 3 Topline: Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Eff

Drug
recent
Indication
Acute Myocardial Infarction

Other upcoming events for VTRS

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evalua
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evalua
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and
Patent ExpiryPatent/Exclusivity Expiry: MOXEZA
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Eff — VTRS Phase 3 Readout | BioSniper